Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio G Mastronardi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Neuroscience Research|February 11, 2005
Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosisFabrizio G Mastronardi, Mario A Moscarello
Neurochemical Research|October 13, 2006
The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosisMario A Moscarello, Fabrizio G Mastronardi, D Denise Wood
Journal of Neuroscience Research|May 1, 2007
Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylatedFabrizio G Mastronardi, Abdul Noor, D Denise Wood, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
The amount of sonic hedgehog in multiple sclerosis white matter is decreased and cleavage to the signaling peptide is deficientFabrizio G Mastronardi, Luis A G daCruz, Huimin Wang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 22, 2005
Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disordersAixiao Liu, Christine Stadelmann, Mario Moscarello, et al.
The Journal of Clinical Investigation|January 3, 2013
Deimination restores inner retinal visual function in murine demyelinating diseaseMabel Enriquez-Algeciras, Di Ding, Fabrizio G Mastronardi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balanceFabrizio G Mastronardi, Weixian Min, Huimin Wang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 30, 2008
Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activitiesDorothy D Wood, Cameron A Ackerley, Ben van den Brand, et al.
Disease Models & Mechanisms|December 19, 2008
Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous systemAbdiwahab A Musse, Zhen Li, Cameron A Ackerley, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 3, 2006
Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocationFabrizio G Mastronardi, D Denise Wood, Jiang Mei, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Neuroscience Research|February 11, 2005
Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosisFabrizio G Mastronardi, Mario A Moscarello
Neurochemical Research|October 13, 2006
The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosisMario A Moscarello, Fabrizio G Mastronardi, D Denise Wood
Journal of Neuroscience Research|May 1, 2007
Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylatedFabrizio G Mastronardi, Abdul Noor, D Denise Wood, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
The amount of sonic hedgehog in multiple sclerosis white matter is decreased and cleavage to the signaling peptide is deficientFabrizio G Mastronardi, Luis A G daCruz, Huimin Wang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 22, 2005
Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disordersAixiao Liu, Christine Stadelmann, Mario Moscarello, et al.
The Journal of Clinical Investigation|January 3, 2013
Deimination restores inner retinal visual function in murine demyelinating diseaseMabel Enriquez-Algeciras, Di Ding, Fabrizio G Mastronardi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balanceFabrizio G Mastronardi, Weixian Min, Huimin Wang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 30, 2008
Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activitiesDorothy D Wood, Cameron A Ackerley, Ben van den Brand, et al.
Disease Models & Mechanisms|December 19, 2008
Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous systemAbdiwahab A Musse, Zhen Li, Cameron A Ackerley, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 3, 2006
Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocationFabrizio G Mastronardi, D Denise Wood, Jiang Mei, et al.
Pageof 2